Skip to content
SOCI - Standing Committee

Social Affairs, Science and Technology

 

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 23 - Minutes of Proceedings


OTTAWA, Thursday, October 25, 2012
(56)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 10:29 a.m., in room 2, Victoria Building, the Honourable Senator Kelvin K. Ogilvie, Chair, presiding.

Members of the committee present: The Honourable Senators Martin, Mercer, Moore, Munson, Ogilvie, Raine, Seidman, Seth and Verner, P.C. (9).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.).

WITNESSES:

Rx&D:

Ken Hughes, Vice-President, Scientific and Regulatory Affairs;

Stan Glezer, Vice-President, Evidence, Value and Access, Sanofi.

Canadian Generic Pharmaceutical Association:

Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc.

BIOTECanada:

Andrew Casey, President and Chief Executive Officer;

Loretta Del Bosco, President and Chief Executive Officer, Regulatory Affairs, Abbott Canada Ltd.

The chair made a statement.

Mr. Hughes, Dr. D'Cunha, Mr. Casey and Ms. Del Bosco each made a statement and, together with Mr. Glezer, answered questions.

At 12:06 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee


Back to top